Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections

Bacteriophages (BPs) are viruses that can infect and kill bacteria without any negative effect on human or animal cells. For this reason, it is supposed that they can be used, alone or in combination with antibiotics, to treat bacterial infections. In this narrative review, the advantages and limitations of BPs for use in humans will be discussed. PubMed was used to search for all of the studies published from January 2008 to December 2018 using the key words: “BPs” or “phages” and “bacterial infection” or “antibiotic” or “infectious diseases.” More than 100 articles were found, but only those published in English or providing evidence-based data were included in the evaluation. Literature review showed that the rapid rise of multi-drug-resistant bacteria worldwide coupled with a decline in the development and production of novel antibacterial agents have led scientists to consider BPs for treatment of bacterial infection. Use of BPs to overcome the problem of increasing bacterial resistance to antibiotics is attractive, and some research data seem to indicate that it might be a rational measure. However, present knowledge seems insufficient to allow the use of BPs for this purpose. To date, the problem of how to prepare the formulations for clinical use and how to avoid or limit the risk of emergence of bacterial resistance through the transmission of genetic material are not completely solved problems. Further studies specifically devoted to solve these problems are needed before BPs can be used in humans.

[1]  C. Torres-Barceló.  The disparate effects of bacteriophages on antibiotic-resistant bacteria , 2018, Emerging Microbes & Infections.

[2]  C. Ubeda,et al.  Role of Staphylococcal Phage and SaPI Integrase in Intra- and Interspecies SaPI Transfer , 2007, Journal of bacteriology.

[3]  A. Srivastava,et al.  Immunological factors that affect the in vivo fate of T7 phage in the mouse. , 2004, Journal of virological methods.

[4]  O. Katare,et al.  Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia. , 2015, The Journal of infectious diseases.

[5]  C. Vervaet,et al.  Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization) , 2013, PloS one.

[6]  R. Young.  Phage lysis: do we have the hole story yet? , 2013, Current opinion in microbiology.

[7]  G. Vergnaud,et al.  The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages , 2013, PloS one.

[8]  C. J. Hovde,et al.  Application of Bacteriophages To Control Intestinal Escherichia coli O157:H7 Levels in Ruminants , 2006, Applied and Environmental Microbiology.

[9]  B. Blasdel,et al.  Compassionate Use of Bacteriophage Therapy for Foot Ulcer Treatment as an Effective Step for Moving Toward Clinical Trials. , 2018, Methods in molecular biology.

[10]  Hanne Rosenquist,et al.  Quantitative risk assessment of human campylobacteriosis associated with thermophilic Campylobacter species in chickens. , 2003, International journal of food microbiology.

[11]  K. Seed.  Battling Phages: How Bacteria Defend against Viral Attack , 2015, PLoS pathogens.

[12]  J. Azeredo,et al.  The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens , 2010, BMC Microbiology.

[13]  H. Brüssow,et al.  In Vitro and In Vivo Bacteriolytic Activities of Escherichia coli Phages: Implications for Phage Therapy , 2004, Antimicrobial Agents and Chemotherapy.

[14]  V. M. Bondarenko,et al.  [The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection]. , 1991, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.

[15]  B. Blasdel,et al.  Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. , 2016, Journal of wound care.

[16]  M. V. van Regenmortel.  Virus species and virus identification: past and current controversies. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  A. Rousseau,et al.  Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. , 2019, The Lancet. Infectious diseases.

[18]  C. Torres-Barceló.  Phage Therapy Faces Evolutionary Challenges , 2018, Viruses.

[19]  M. Eschbach,et al.  Evidence that TraT interacts with OmpA of Escherichia coli , 1986, FEBS letters.

[20]  S. Sillankorva,et al.  Bacteriophage Therapy , 2018, Methods in Molecular Biology.

[21]  E. V. Afanas’eva,et al.  [Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages]. , 1992, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.

[22]  T. Callaway,et al.  Evolution of foodborne pathogens via temperate bacteriophage-mediated gene transfer. , 2005, Foodborne pathogens and disease.

[23]  D. Barceló,et al.  Occurrence of antibiotics and antibiotic resistance genes in hospital and urban wastewaters and their impact on the receiving river. , 2015, Water research.

[24]  A. Forsgren,et al.  Effect of Protein A on Adsorption of Bacteriophages to Staphylococcus aureus , 1974, Journal of virology.

[25]  M. Kutateladze,et al.  Bacteriophages as potential new therapeutics to replace or supplement antibiotics. , 2010, Trends in biotechnology.

[26]  Yoon-Jae Song,et al.  Safety of using Escherichia coli bacteriophages as a sanitizing agent based on inflammatory responses in rats , 2016, Food Science and Biotechnology.

[27]  L. Krause,et al.  Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. , 2012, Virology.

[28]  M.H.V. Van Regenmortel,et al.  Virus species and virus identification: past and current controversies. , 2007 .

[29]  L. Touqui,et al.  Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention , 2011, PloS one.

[30]  Martha R. J. Clokie,et al.  Phages in nature , 2011, Bacteriophage.

[31]  J. Gill,et al.  Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. , 2010, The Journal of infectious diseases.

[32]  J. Jofre,et al.  Antibiotic Resistance Genes in the Bacteriophage DNA Fraction of Human Fecal Samples , 2013, Antimicrobial Agents and Chemotherapy.

[33]  E. Kutter,et al.  Evaluation of lytic activity of staphylococcal bacteriophage Sb‐1 against freshly isolated clinical pathogens , 2011, Microbial biotechnology.

[34]  E. Bingen,et al.  Efficacy of Bacteriophage Therapy in Experimental Sepsis and Meningitis Caused by a Clone O25b:H4-ST131 Escherichia coli Strain Producing CTX-M-15 , 2012, Antimicrobial Agents and Chemotherapy.

[35]  W. Fortuna,et al.  Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. , 2007, Postepy higieny i medycyny doswiadczalnej.

[36]  K. M. Shaw,et al.  Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. , 1987, Journal of general microbiology.

[37]  N. Tikunova,et al.  Bacteriophage Treatment of Infected Diabetic Foot Ulcers. , 2018, Methods in molecular biology.

[38]  E. Anggard,et al.  Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. , 2010, Veterinary microbiology.

[39]  K. M. Shaw,et al.  The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. , 1987, Journal of general microbiology.

[40]  H. Smith,et al.  Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. , 1982, Journal of general microbiology.

[41]  Peter C. Fineran,et al.  A century of the phage: past, present and future , 2015, Nature Reviews Microbiology.

[42]  E. Änggård,et al.  A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[43]  Rob Lavigne,et al.  Learning from Bacteriophages - Advantages and Limitations of Phage and Phage-Encoded Protein Applications , 2012, Current protein & peptide science.

[44]  M. Kutateladze,et al.  Phage therapy experience at the Eliava Institute. , 2008, Medecine et maladies infectieuses.

[45]  M. Kutateladze,et al.  Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report. , 2018, Research in microbiology.

[46]  B. Berger,et al.  Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh , 2016, EBioMedicine.

[47]  S. Abedon,et al.  Phage treatment of human infections , 2011, Bacteriophage.

[48]  C. Pringle,et al.  Abbreviations for bacterial and fungal virus species names , 2000, Archives of Virology.

[49]  S. Faruque,et al.  Phase Variable O Antigen Biosynthetic Genes Control Expression of the Major Protective Antigen and Bacteriophage Receptor in Vibrio cholerae O1 , 2012, PLoS pathogens.

[50]  S. Zuber,et al.  Amplification and Purification of T4-Like Escherichia coli Phages for Phage Therapy: from Laboratory to Pilot Scale , 2013, Applied and Environmental Microbiology.

[51]  M. Weinbauer.  Ecology of prokaryotic viruses. , 2004, FEMS microbiology reviews.

[52]  J..  Treatment of experimental infections of mice with bacteriophages , 2008 .

[53]  A. Donoghue,et al.  Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection. , 2003, Poultry science.

[54]  J. Soothill.  Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. , 1994, Burns : journal of the International Society for Burn Injuries.

[55]  J. Balcázar,et al.  Metagenomic analysis reveals that bacteriophages are reservoirs of antibiotic resistance genes. , 2016, International journal of antimicrobial agents.

[56]  R. Katsarava,et al.  A novel sustained‐release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds , 2002, International journal of dermatology.

[57]  L. Krause,et al.  Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. , 2013, Virology.

[58]  Mark R. Liles,et al.  Identification of Diverse Antimicrobial Resistance Determinants Carried on Bacterial, Plasmid, or Viral Metagenomes from an Activated Sludge Microbial Assemblage , 2010, Applied and Environmental Microbiology.

[59]  J. Jofre,et al.  Quinolone resistance genes (qnrA and qnrS) in bacteriophage particles from wastewater samples and the effect of inducing agents on packaged antibiotic resistance genes. , 2014, The Journal of antimicrobial chemotherapy.

[60]  R. Simons,et al.  Reverse Transcriptase-Mediated Tropism Switching in Bordetella Bacteriophage , 2002, Science.

[61]  P. Domingo-Calap,et al.  Bacteriophages: Protagonists of a Post-Antibiotic Era , 2018, Antibiotics.

[62]  V. Vlassov,et al.  Applications of Bacteriophages in the Treatment of Localized Infections in Humans , 2018, Front. Microbiol..

[63]  T. Majka,et al.  T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production , 2013, PloS one.

[64]  C. Desnues,et al.  Bacteriophages as vehicles of the resistome in cystic fibrosis. , 2011, The Journal of antimicrobial chemotherapy.

[65]  J. Balcázar,et al.  Bacteriophages as a reservoir of extended-spectrum β-lactamase and fluoroquinolone resistance genes in the environment. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[66]  James J. Collins,et al.  Dispersing biofilms with engineered enzymatic bacteriophage , 2007, Proceedings of the National Academy of Sciences.

[67]  N. Chanishvili.  Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches. , 2012, Advances in virus research.

[68]  I. Huys,et al.  Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains , 2018, Viruses.

[69]  C. Hill,et al.  Bacteriophages ϕMR299-2 and ϕNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells , 2012, mBio.

[70]  S. Abedon,et al.  This Reprint May Differ from the Original in Pagination and Typographic Detail. On-demand Isolation of Bacteriophages against Drug-resistant Bacteria for Personalized Phage Therapy On-demand Isolation of Bacteriophages against Drug- Resistant Bacteria for Personalized Phage Therapy , 2022 .

[71]  A. Górski,et al.  Molecular imaging of T4 phage in mammalian tissues and cells , 2014, Bacteriophage.

[72]  I. Connerton,et al.  Bacteriophage Therapy To Reduce Campylobacter jejuni Colonization of Broiler Chickens , 2005, Applied and Environmental Microbiology.

[73]  H. Smith,et al.  Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. , 1983, Journal of general microbiology.

[74]  M. Vaneechoutte,et al.  Experimental phage therapy of burn wound infection: difficult first steps. , 2014, International journal of burns and trauma.

[75]  H. Badran.  Bacteriophage therapy of Pseudomonas burn wound sepsis , 1994 .

[76]  M. Perros.  A sustainable model for antibiotics , 2015, Science.

[77]  C. Desnues,et al.  Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota. , 2011, The Journal of antimicrobial chemotherapy.

[78]  H. Myung,et al.  Observation of inflammatory responses in mice orally fed with bacteriophage T7 , 2014, Journal of applied microbiology.

[79]  W. Summers.  Cholera and plague in India: the bacteriophage inquiry of 1927-1936. , 1993, Journal of the history of medicine and allied sciences.

[80]  A. Górski,et al.  Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface , 2014, Journal of Virology.

[81]  José Luis Balcázar,et al.  Exploring the contribution of bacteriophages to antibiotic resistance. , 2017, Environmental pollution.

[82]  Yvonne A O'Shea,et al.  Mobilization of the Vibrio pathogenicity island between Vibrio cholerae isolates mediated by CP-T1 generalized transduction. , 2002, FEMS microbiology letters.

[83]  M. Kuskowski,et al.  Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. , 2009, Journal of wound care.

[84]  N. Friedman,et al.  Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes , 2011, Applied and Environmental Microbiology.

[85]  W. A. Clark.  Comparison of several methods for preserving bacteriophages. , 1962, Applied microbiology.

[86]  F. D'Herelle.  Bacteriophage as a Treatment in Acute Medical and Surgical Infections. , 1931, Bulletin of the New York Academy of Medicine.

[87]  D. Barceló,et al.  Abundance of antibiotic resistance genes and bacterial community composition in wild freshwater fish species. , 2018, Chemosphere.

[88]  R. Lavigne,et al.  Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials. , 2015, Annual review of virology.

[89]  J. Soothill.  Treatment of experimental infections of mice with bacteriophages. , 1992, Journal of medical microbiology.

[90]  I. Vachier,et al.  Effectiveness of bacteriophages in the sputum of cystic fibrosis patients. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[91]  Bondarenko Vm,et al.  The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection , 1991 .

[92]  M. Sullivan,et al.  Phages rarely encode antibiotic resistance genes: a cautionary tale for virome analyses , 2016, The ISME Journal.

[93]  P. Ringwald,et al.  Antimicrobial resistance. , 2001, Emerging infectious diseases.

[94]  Athanasios Kakasis,et al.  Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. , 2019, International journal of antimicrobial agents.

[95]  N. Chanishvili.  Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences. , 2016, Current drug delivery.